Characterization of trans-Resveratrol-Loaded Lipid-Core Nanocapsules and Tissue Distribution Studies in Rats

被引：150
作者：
Frozza, Rudimar L. [1 ]
Bernardi, Andressa [2 ]
Paese, Karina [2 ]
Hoppe, Juliana B. [1 ]
da Silva, Thaline [1 ]
Battastini, Ana M. O. [1 ]
Pohlmann, Adriana R. [2 ,3 ]
Guterres, Silvia S. [2 ]
Salbego, Christianne [1 ]
机构：
[1] Univ Fed Rio Grande do Sul, Dept Bioquim, Inst Ciencias Basicas Saude, BR-90035003 Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Programa Posgrad Ciencias Farmaceut, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil
[3] Univ Fed Rio Grande do Sul, Programa Posgrad Quim, Inst Quim, BR-91501970 Porto Alegre, RS, Brazil
来源：
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY | 2010年 / 6卷 / 06期
关键词：
trans-Resveratrol; Nanocapsule; Drug Delivery; Physical Stability; Biodistribution; BLOOD-BRAIN-BARRIER; TARGETED DELIVERY; SMALL-INTESTINE; NANOPARTICLES; BIOAVAILABILITY; INSTABILITY; METABOLISM; ABSORPTION; PARTICLES; PEPTIDES;
D O I：
10.1166/jbn.2010.1161
中图分类号：
TB3 [工程材料学];
学科分类号：
0805 ; 080502 ;
摘要：
Several studies have reported that orally ingested trans-resveratrol is extensively metabolized in the enterocyte before it enters the blood and target organs. Additionally, trans-resveratrol is photosensitive, easily oxidized and presents unfavorable pharmacokinetics. Therefore, it is of great interest to stabilize trans-resveratrol in order to preserve its biological activities and to improve its bioavailability in the brain. Here, trans-resveratrol was loaded into lipid-core nanocapsules and analyzed for particle size, polydispersity and zeta potential. The nanocapsule distribution in brain tissue was evaluated by intraperitoneal (i.p.) and gavage routes in healthy rats. The lipid-core nanocapsules had a mean diameter of 241 nm, a polydispersity index of 0.2, and a zeta potential of -15 mV. No physical changes were observed after 1, 2 and 3 months of storage at 25 degrees C. Lipid-core nanocapsules showed high entrapment of trans-resveratrol and displayed a higher trans-resveratrol concentration in the brain, the liver and the kidney after daily i.p. or gavage administration than that observed for the free trans-resveratrol. Because trans-resveratrol is a potent cyclooxygenase-1 inhibitor, gastrointestinal damage was evaluated. The animals that were administered with trans-resveratrol-loaded lipid-core nanocapsules showed significantly less damage when compared to those administered with free trans-resveratrol. In summary, lipid-core nanocapsules exhibited great trans-resveratrol encapsulation efficiency. trans-Resveratrol-loaded lipid-core nanocapsules increased the concentration of trans-resveratrol in the brain tissue. Gastrointestinal safety was improved when compared with free trans-resveratrol. Thus, trans-resveratrol-loaded lipid-core nanocapsules may be used as an alternative potential therapeutic for several diseases including Alzheimer's disease.
引用
收藏
页码：694 / 703
页数：10
相关论文
共 39 条
  • [31] Transmucosal macromolecular drug delivery
    Prego, C
    García, M
    Torres, D
    Alonso, MJ
    [J]. JOURNAL OF CONTROLLED RELEASE, 2005, 101 (1-3) : 151 - 162
  • [32] Protective properties of melatonin-loaded nanoparticles against lipid peroxidation
    Schaffazick, SR
    Pohlmann, AR
    de Cordova, CAS
    Creczynski-Pasa, TB
    Guterres, SS
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 289 (1-2) : 209 - 213
  • [33] Shakweh Monjed, 2004, Expert Opin Drug Deliv, V1, P141, DOI 10.1517/17425247.1.1.141
  • [34] Resveratrol: A molecule whose time has come? And gone?
    Soleas, GJ
    Diamandis, EP
    Goldberg, DM
    [J]. CLINICAL BIOCHEMISTRY, 1997, 30 (02) : 91 - 113
  • [35] Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2 - A mechanistic approach to the design of COX-1 selective agents
    Szewczuk, LM
    Forti, L
    Stivala, LA
    Penning, TM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) : 22727 - 22737
  • [36] Design of biodegradable particles for protein delivery
    Vila, A
    Sánchez, A
    Tobío, M
    Calvo, P
    Alonso, MJ
    [J]. JOURNAL OF CONTROLLED RELEASE, 2002, 78 (1-3) : 15 - 24
  • [37] High absorption but very low bioavailability of oral resveratrol in humans
    Walle, T
    Hsieh, F
    DeLegge, MH
    Oatis, JE
    Walle, UK
    [J]. DRUG METABOLISM AND DISPOSITION, 2004, 32 (12) : 1377 - 1382
  • [38] Metabolism and bioavailability of trans-resveratrol
    Wenzel, E
    Somoza, V
    [J]. MOLECULAR NUTRITION & FOOD RESEARCH, 2005, 49 (05) : 472 - 481
  • [39] Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease
    Wilson, Barnabas
    Samanta, Malay Kumar
    Santhi, Kumaraswamy
    Kumar, Kokilampal Perumal Sampath
    Paramakrishnan, Nallupillai
    Suresh, Bhojraj
    [J]. BRAIN RESEARCH, 2008, 1200 : 159 - 168
1234